Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 08:21 am Purchase |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LP | 2,555,000 6.430% |
155,000 (+6.46%) |
Filing History |
| 2021-02-16 08:20 am Purchase |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 5,000,000 6.650% |
1,000,000 (+25.00%) |
Filing History |
| 2021-02-16 08:19 am Sale |
2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Camber Capital Management LP | 0 0.000% |
-118,000 (Position Closed) |
Filing History |
| 2020-11-30 10:57 am Purchase |
2020-11-20 | 13G | AVROBIO, Inc. AVRO |
Camber Capital Management LP | 261,111 7.560% |
261,111 (New Position) |
Filing History |
| 2020-07-13 4:06 pm Purchase |
2020-07-07 | 13G | Change Healthcare Inc. CHNG |
Camber Capital Management LP | 16,600,000 5.470% |
16,600,000 (New Position) |
Filing History |
| 2020-06-29 6:03 pm Purchase |
2020-06-18 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LP | 2,400,000 6.100% |
2,400,000 (New Position) |
Filing History |
| 2020-06-22 10:01 am Purchase |
2020-06-11 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 4,000,000 5.370% |
2,500,000 (+166.67%) |
Filing History |